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ABSTRACT 
Marked disturbance in eating behaviour and 
obesity are common sequelae of hypothalamic 
damage. To investigate whether these were 
associated with dysfunctional leptin central 
feedback, we evaluated serum leptin and leptin 
binding activity in 37 patients (age 3.5-21 yr) with 
tumour or trauma involving the hypothalamic-
pituitary axis compared with 138 healthy child-
ren (age 5.0-18.2 yr). Patients were subdivided by 
BMI <2 SDS or >2 SDS and healthy children and 
children with simple obesity of comparable age 
and pubertal status served as controls. Patients 
had higher BMI (mean 1.9 vs 0.2 SDS; ρ <0.001), 
a greater proportion had BMI >2 SDS (54% vs 
8%; ρ <0.001) and higher serum leptin (mean 2.1 
vs 0.04 SDS; ρ <0.001) than healthy children. 
Serum leptin (mean 1.1 vs -0.1 SDS; ρ = 0.004) 
and values adjusted for BMI (median 0.42 vs 0.23 
μg/l:kg/m2; ρ = 0.02) were higher in patients with 
BMI <2 SDS. However, serum leptin adjusted for 
BMI was similar in patients with BMI >2 SDS 
compared to corresponding controls (1.08 vs 0.95; 
ρ = 0.6). Log serum leptin correlated with BMI 
SDS in all subject groups but the relationship in 
patients with BMI <2 SDS was of higher magni-
tude (r = 0.65, slope = 0.29, ρ =0.05 for difference 
between slopes) than in healthy controls (r = 0.42, 
slope = 0.19). Serum leptin binding activity 
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(median 7.5 vs 9.3%; ρ = 0.02) and values 
adjusted for BMI (median 0.28 vs 0.48 %.m2/kg; 
ρ <0.001) were lower in patients than in healthy 
children. The markedly elevated leptin levels with 
increasing BMI in non-obese patients with 
hypothalamic-pituitary damage are suggestive of 
an unrestrained pattern of leptin secretion. This 
along with low leptin binding activity and hence 
higher free leptin levels would be consistent with 
central leptin insensitivity. 
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INTRODUCTION 
Leptin, generated in adipocytes, is believed to 
reduce appetite by a central action on the hypo-
thalamus and suppression of its primary appetite 
transducer, neuropeptide Υ (NPY)'. The unregulated 
appetite and body weight gain commonly seen in 
children with hypothalamic injury2'3 may be 
explained by dysfunctional leptin central feedback. 
Previous studies have reported an increase in serum 
leptin in parallel with the postoperative increase in 
body mass index (BMI) in patients with cranio-
pharyngioma4,5. A further study showed higher leptin 
concentrations in relation to BMI in patients with 
suprasellar craniopharyngioma compared to those 
with an intrasellar tumour6. Leptin binding activity, 
which corresponds to the extracellular domain of the 
leptin receptor, reflects the amount of circulating free 
leptin available for inhibitory feedback. High serum 
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leptin concentrations7 but lower leptin binding 
activity in obese compared with lean subjects 
suggests that the obese have higher free levels of 
leptin8"10. However, as this does not lead to decreased 
caloric intake and increased energy expenditure, it is 
likely that obese subjects are insensitive to endo-
genous leptin. Serum leptin binding activity has not 
previously been investigated in patients with 
hypothalamic lesions. 
The aim of this study was to evaluate (1) serum 
leptin and leptin binding activity in children with 
tumour or trauma involving the hypothalamic-
pituitary axis, and (2) the influence of body 
composition and treatment-related factors on these 
biochemical variables. 
PATIENTS AND METHODS 
All patients (n = 37; median age 14.4 yr, range 
3.5-21 yr; 15 female) under our care, aged <21 years 
excluding one very young patient (age 0.8 yr), with a 
sellar or suprasellar lesion (28 craniopharyngioma, 4 
germinoma, 1 optic nerve glioma, 2 astrocytoma, 2 
head trauma) were studied. Of these, all had had 
cranial surgery and 24 had also received radio-
therapy. Patients with pituitary hormone deficiency 
(Table 1) were receiving appropriate hormone 
replacement (median doses: GH 16.8 IU/m2/wk; 
hydrocortisone 9.7 mg/m2/d; thyroxine 63.1 μg/m2/d; 
desmopressin 107.1 μg/d; increasing doses of 
ethinyloestradiol or testosterone esters in adolescent 
patients) and were under review in a regional centre. 
Twelve of the 14 females and 18 of the 23 males 
were pubertal. Patients were categorised according to 
pubertal status (breast development for females and 
genital development for males) as prepubertal (B1 or 
Gl) and pubertal (Tanner stages B2-5 or G2-5). 
Height, weight, four skinfold measurements (triceps, 
biceps, supra-iliac and sub-scapular), serum leptin 
and leptin binding activity were assessed at a median 
time of 5.8 yr (range 0.2-18 yr) after diagnosis or 
cranial surgery. BMI (weight/height2), fat mass (from 
summed skinfold thicknesses)", fat free mass 
(weight - fat mass) and percent body fat (fat mass 
expressed as a percent of weight) were calculated. 
Height, weight and BMI were converted to standard 
deviation scores (SDS) using 1990 UK standards12,13. 
Blood samples for serum leptin and leptin binding 
activity were taken from 2-4 h after a meal, 
coincident with thyroid function monitoring. 
Patients were compared with 138 local healthy 
school children (age 5.0-18.2 yr). The latter were 
selected to obtain a representative distribution of 
males and females and children at different stages of 
puberty. Those with chronic medical conditions or in 
receipt of regular medication were excluded. 
However, the distribution of BMI SDS differed 
significantly between patients and these healthy 
children. Thus for further analysis patients were 
subdivided by BMI <2 SDS or >2 SDS. For 
comparison to these subgroups, a group of healthy 
children and children with simple obesity matched 
for age and pubertal status whose BMI was in a 
similar range served as controls (Table 2). The 
children with simple obesity were identified from all 
patients referred to the endocrine unit for obesity 
(BMI >2 SDS) and did not have a hypothalamic-
pituitary lesion, Prader-Willi syndrome, Cushing's 
syndrome or other recognised obesity syndrome. 
TABLE 1 
Details of pituitary hormone deficiencies in patients grouped by diagnosis 
Hormone deficiency 
GH ACTH TSH LH, FSH ADH 
Craniopharyngioma (η = 28) 28 26 28 15* 24 
Other tumour (η = 7) 5 5 5 3* 3 
Trauma (n = 2) 2 2 2 2* 2 _ 
* Exc lud ing prepuber ta l pat ients 
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TABLE 2 
Clinical characteristics and biochemical values of patients with hypothalamic lesions 
subdivided by BMI <2 S D S or >2 S D S and compared with healthy and obese children 
Patients Healthy children ρ 
Body mass index <2 S D S 
total number 17 57 -
number of males 13 39 0.5 
number pubertal 14 50 0.6 
median age yr ( I Q R ) 14.6 (10.9 to 17.2) 13.4 (11.6 to 15.3) 0.3 
mean body mass index S D S (SD) 0.9 (0.9) 0.4 (0.7) 0.02 
median serum leptin μ§/1 ( I Q R ) 9.2 (4.4 to 17.6) 4.5 (2.3 to 9.4) -
mean log se rum leptin (SD) 0.94 (0.39) 0.67 (0.34) 0.02 
mean serum leptin S D S (SD) 1.1(1.3) -0.1 (0.9) 0.004 
median serum leptin/BMI μg/l:kg/m2 ( I Q R ) 0.42 (0.27 to 0.72) 0.23 (0.13 to 0.45) 0.02 
log serum leptin vs body mass index S D S r = 0.65 
r2 = 38% 
slope = 0.29 
ρ = 0.05 
r = 0.42 
r 2 = 16% 
slope = 0.19 
ρ = 0.001 
0.03 
Body mass index >2 S D S 
total number 17 28 -
number of males 8 14 0.8 
number pubertal 13 18 0.4 
median age yr ( I Q R ) 13.8 (9.2 to 15.6) 12.6 (9.6 to 13.7) 0.1 
mean body mas s index S D S (SD) 2.6 (0.6) 3.1 (0.7) 0.03 
median serum leptin μg/l ( I Q R ) 26.9(18.4 to 47.6) 26.8 (16.0 to 53.4) -
mean log se rum leptin (SD) 1.46 (0.29) 1.44 (0.36) 0.9 
mean serum leptin S D S (SD) 2 .9(1 .3 ) 6.4 (6.9) 0.01 
median serum leptin/BMI μg/l:kg/m2 ( I Q R ) 1.08 (0.72 to 1.57) 0.95 (0.63 to 1.35) 0.6 
log serum leptin vs B M I S D S r = 0.68 
r2 = 43% 
slope = 0.35 
ρ = 0.003 
r = 0.66 
r2 = 42% 
slope = 0.34 
Ρ <0.001 
0.4 
Values shown are mean or median and standard deviation (SD) or interquartile range (IQR). 
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Biochemical assays 
Serum leptin concentrations were determined 
using a commercial radioimmunoassay (Linco, St 
Charles, MO, USA). The limit of detection of the 
assay was 0.5 j_ig/l. The intra- and interassay 
coefficients of variation (CVs) ranged from 3.4-8.3% 
and 3.6-6.2%, respectively, over a leptin concen-
tration range of 4.9-25.6 μ^Ι. Values were log-
transformed prior to analyses and also expressed as 
age, gender and puberty specific SD scores using 
reference values obtained from our local population 
of 235 healthy children (age 4.9-18.4 yr; 125 
female)14. Serum leptin values in healthy adolescents 
at genitalia/breast stage 5 do not differ significantly 
from those in young adults aged 18-21 years and 
were therefore used to construct SD scores for the 
three patients older than 18.4 years15. 
Serum leptin binding activity was measured by an 
assay specific for high-affinity binding proteins and 
based on a method for growth hormone binding 
protein16. Serum was stripped of endogenous free 
leptin by preincubation with dextran-coated charcoal. 
Stripped serum was incubated with buffer, [125I]-
leptin, in the presence (nonspecific) or absence (total 
binding) of unlabeled leptin, and the supernatant was 
analysed in an automatic gamma counter. The 
specific binding (total binding minus nonspecific 
binding) obtained was expressed as a percentage of 
the total [125I]leptin counts per minute incubated in 
50 μΐ of serum and called leptin binding activity. The 
assay had a sensitivity of 0.6% specific binding. At 
12 and 6% specific binding, the intra-assay CV was 
3.2 and 4.1%, and the interassay CV was 6.4 and 
4.8%, respectively. 
Statistical analysis 
Normally and non-normally distributed variables 
were compared using Student's /-test or Mann-
Whitney U test, respectively. Values at different 
puberty stages were examined by analysis of 
variance. Pearson correlations and regression 
analysis were performed to investigate relationships. 
Backward regression analysis was used to assess the 
effects of independent variables (% body fat, BMI 
SDS, age, pubertal stage, time from diagnosis, 
treatment, use of radiotherapy and leptin binding 
activity) on leptin concentration. A ρ value <0.05 
was considered significant. 
RESULTS 
Body mass index and body fat 
Patients had significantly higher BMI than 
healthy children (mean 1.9 vs 0.2 SDS; ρ <0.001). 
Of the 37 patients, only two (5%) had BMI SDS <0 
while 20 (54%) had BMI SDS >2.0. BMI did not 
differ between males (mean 1.8 SDS, SD 1.0) and 
females (mean 1.7 SDS, SD 1.6). Skinfold measure-
ments could not be obtained in five patients due to 
extreme obesity. The correlation between BMI and 
body fat derived from summed skinfolds was high 
(r = 0.91, r2 = 83%, ρ <0.001). Body fat was elevated 
in male and female patients compared to reported 
values in healthy children (males: mean 33.5 vs 
13.2%, ρ <0.0001; females: mean 32.2 vs 19.8%, 
ρ = 0.02)'°. 
Serum leptin and serum leptin adjusted for BMI 
Serum leptin levels were higher in patients than 
in healthy children (mean 2.1 vs 0.04 SDS; 
ρ <0.001). Levels in patients did not differ between 
males and females (mean 2.3 vs 1.9 SDS). Owing to 
the differences in BMI SDS between patients and 
controls, serum leptin was adjusted for BMI and 
these values were also higher in patients (median 
0.73 vs 0.26 μg/l:kg/m2; ρ <0.001) (Fig. 1). How-
ever, in the analysis of subgroups this difference was 
only observed between patients and controls with 
BMI <2 SDS but not in those with BMI >2 SDS 
(Table 2). 
Relationship between log serum leptin, BMI SDS 
and other variables 
Log serum leptin correlated significantly with 
BMI SDS (r = 0.81, r2 = 64%, ρ <0.001) and body 
fat % (r = 0.76, r2 = 54%, ρ <0.001) in patients. The 
relationship between log serum leptin and BMI SDS 
was of higher magnitude in patients (r = 0.65, 
r2 = 38%, slope = 0.29) than in controls (r = 0.42, 
r2 = 16%, slope = 0.19; ρ = 0.03 for difference 
between slopes) in the subgroups with BMI <2 SDS, 
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Fig. 1: Serum leptin adjus ted for BMI ^ g / l : k g / m 2 ) at different pubertaal stages (genital ia and breast development for males and 
females, respectively) in patients compared with those from healthy children. Box-whisker plots represent median, inter-
quarti le range and range for healthy children, and points represent values for individual patients. Values for patients were 
higher than for healthy children (p <0 .001; 9 5 % CI 0.27 to 0.60). 
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Fig. 2: Serum leptin b inding activity adjusted for BMI (%.m 2 /kg) at different pubertal s tages (genital ia and breast deve lopment 
for males and females , respectively) in patients compared with those from healthy chi ldren. Box-whisker plots represent 
median, inter-quartile range and range for healthy children, and points represent values for individual patients. Values for 
patients were lower than for healthy children (p <0.001; 9 5 % CI 0.29 to -0.11) . 
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but did not differ (p = 0.4) in the subgroups with 
BMI >2 SDS (Table 2). 
In backward multiple regression, log serum leptin 
was significantly determined by BMI SDS, gender 
and pubertal stage (log leptin = 0.97 + 0.29 BMI 
SDS - 0.29 gender + 0.07 pubertal stage; r2 = 70%, 
ρ <0.001). BMI SDS (r = -0.53, r2 = 26%, ρ = 0.002) 
and log serum leptin (r = -0.45, r2 = 18%, ρ = 0.009) 
correlated inversely with hydrocortisone replacement 
dose. However, including hydrocortisone dose in the 
regression analysis did not explain greater variability 
in the relationship between log serum leptin and 
BMI SDS (62% vs 63%). 
GH replacement dose (r = -0.01), thyroxine 
replacement dose (r = -0.14), treatment with sex 
steroids (r = 0.31, ρ = 0.07), time from diagnosis 
(r = 0.22) and use of radiotherapy (r = 0.24) had no 
significant influence on serum leptin. Log serum 
leptin did not correlate significantly with height SDS 
(r = 0.35). 
Serum leptin binding activity 
Serum leptin binding activity (median 7.5 vs 
9.3%; ρ = 0.02) and values adjusted for BMI 
(median 0.28 vs 0.48 %.m2/kg; ρ <0.001) were lower 
in patients than in healthy children (Fig. 2). Serum 
leptin binding activity was lower in pubertal (median 
6.9%) than prepubertal patients (median 10%; 
ρ = 0.01) and also in pubertal (median 7.5%) 
than prepubertal healthy children (median 11.8%; 
ρ <0.001). Bound and free serum leptin were 
estimated from measured values of serum leptin and 
leptin binding activity and expressed as age-, gender-
and puberty-specific SD scores using values estima-
ted from healthy children. Both bound (mean 5.5 
SDS; ρ <0.001) and free serum leptin (mean 6.0 
SDS; ρ <0.001) were found to be higher in patients. 
Serum leptin binding activity correlated inversely 
with serum leptin in healthy females (r = -0.42, 
r 16%, ρ <0.001) and female patients (r = -0.73, r = 
49%, ρ = 0.005) but not in healthy males (r = 0.03) 
nor male patients (r = -0.12). Serum leptin binding 
activity also correlated inversely with BMI SDS in 
female patients (r = -0.69, r2 = 43%, ρ = 0.009) but 
not male patients (r = 0.06). The significant inverse 
relationship between serum leptin binding activity 
and age-puberty subgroups in healthy children 
(p <0.001 and values at B/G 2 to 5 lower than at 
B/G 1) was lost in patients. 
Influence of radiotherapy 
BMI SDS (p = 0.4), body fat % (p = 0.4), serum 
leptin SDS (p = 0.3) and serum leptin binding 
activity (p = 1.0) did not differ between patients 
treated and not treated with radiotherapy. 
DISCUSSION 
Despite the absence of direct body fat measure-
ments and the limited accuracy of body fat estimated 
from skinfolds, we observed a significant correlation 
between estimated body fat and BMI in patients. The 
altered body composition in this group of patients 
with hypothalamic-pituitary lesions was associated 
with elevated leptin concentrations, in keeping with 
previous observations4"6. Possible explanations for 
elevated leptin concentrations include unrestrained 
secretion from defective negative feedback mecha-
nisms or reduced leptin clearance. The latter may be 
influenced by leptin binding activity and associated 
with more leptin being bound or by hormone 
replacement treatment. In our study, we found no 
evidence in support of either of these. Within the 
group of 37 patients, 54% had BMI SDS >2.0. 
Nevertheless, the remainder had a BMI within the 
normal range. The relationship between leptin and 
BMI SDS in these patients had a steeper slope than 
that seen in normal children. This indicates that non-
obese patients with hypothalamic damage were 
generating more leptin for each unit of BMI than 
controls with the same BMI. For those with BMI 
>2.0, however, leptin concentrations and levels 
adjusted for BMI were similar to those in children 
with simple obesity, indicating that control of leptin 
secretion is comparable. The markedly elevated 
leptin levels with increasing BMI in non-obese 
patients is suggestive of an unrestrained pattern of 
leptin secretion. Thus those children with normal 
BMI who have hypothalamic damage are not 
showing appropriate control of leptin. 
Exogenous glucocorticoid administration is 
known to increase leptin levels and have an 
inhibitory effect on central leptin action. However, 
hydrocortisone replacement for ACTH deficiency is 
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not likely to explain the high leptin levels in our 
patients as they showed an inverse relationship 
between hydrocortisone dose and leptin concen-
tration. One explanation for this may be relative 
underdosing in the obese with a replacement dose 
based on surface area. GH deficiency (GHD) was not 
likely to account for the high leptin levels in our 
patients as all were on appropriate replacement 
treatment and levels were higher than those 
previously observed in untreated and treated patients 
with GHD'7. Adolescent patients with gonadotrophin 
deficiency received treatment with ethinyloestradiol 
or testosterone esters. Although the timing and 
dosage increments of this treatment may be far from 
physiological it did not have a significant effect on 
serum leptin concentrations. However, owing to the 
small number of patients involved in analysis of 
subgroups by treatment as well as gender, pubertal 
status and BMI, caution is required in interpreting 
our results as a type II error cannot be excluded. 
Obesity, predominantly in females18 and associ-
ated with hyperleptinaemia'9, has been reported in 
young adults with hypothalamic damage following 
cranial irradiation for childhood leukaemia. A 
proposed explanation for the leptin resistance in 
these patients is damage to hypothalamic neurons 
which mediate leptin action. Simple obesity has also 
been considered a state of leptin resistance, in which 
increased body fat is matched by increased leptin. 
The leptin resistance is not due to increased binding 
of leptin to circulating proteins, and levels of free 
leptin are higher in obese individuals8"10. From our 
results, this situation appears to hold in patients with 
hypothalamic damage. Serum leptin binding activity 
for BMI, not previously reported with hypothalamic 
damage, was low in our patients. This in conjunction 
with high leptin levels indicates increased levels of 
free leptin and lends further support to the central 
leptin resistance theory. The mechanism for reduc-
tion in leptin binding activity in these children is not 
clear. However, low leptin binding activity when 
adjusted for BMI implies that the central hypo-
thalamic damage may be having an effect on the 
peripheral generation of soluble truncated leptin 
receptor. 
Investigation of serum and cerebrospinal fluid 
leptin concentrations suggests that leptin enters the 
brain by a saturable transport system20. The mecha-
nism of leptin resistance in simple obesity is not yet 
understood but one possibility is reduced efficacy of 
brain leptin transport21,22. Leptin transport into the 
cerebrospinal fluid in patients with hypothalamic 
dysfunction has not been investigated. However, it 
may be postulated that the saturable mechanism 
operates, but that leptin which is available in the 
central nervous system has no hypothalamic target, 
as this has been destroyed by tumour, surgery and/or 
radiotherapy. Some support for this theory comes 
from the reported association between the severity of 
hypothalamic damage identified on MRI scanning 
after surgery for craniopharyngioma and weight 
gain23. All tumour patients had had cranial surgery 
and we therefore were not able to examine the effect 
of the lesion itself or of radiotherapy alone. 
However, we did not find any differences in serum 
leptin concentrations between those who had had 
surgery alone compared to surgery and radiotherapy. 
NPY is the primary physiological appetite trans-
ducer in the hypothalamus and is reduced in rodent 
models of hyperphagia and obesity experimentally 
induced by lesions in and around the hypothalamus24. 
Disturbances in NPY expression and signalling 
remain to be investigated in patients with hypo-
thalamic lesions associated with tumours, surgery, 
radiotherapy or trauma. Modulation of the leptin-
hypothalamic-adipose tissue axis to improve leptin 
sensitivity or alter NPY secretion, in order to affect 
satiety and reduce obesity, may not be achievable in 
patients with structural damage to the hypothalamus. 
Hyperinsulinaemia associated with hyperphagia 
and obesity has been reported in patients with cranio-
pharyngioma5,25 and other hypothalamic insults26. 
Although desirable, serum insulin levels were not 
measured in our patients, and information about 
calorie intake and energy expenditure was not 
available. Increased secretion of insulin owing to 
disinhibition of vagal tone to pancreatic ß-cells, 
secondary to hypothalamic damage, has been 
proposed as another explanation for hypothalamic 
obesity26. Reduction in insulin secretion was 
associated with weight loss and fall in leptin levels in 
a study of eight children with hypothalamic obesity 
treated with octreotide26. Treatment with this 
somatostatin receptor agonist analogue which 
attenuates insulin secretion requires further study. 
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We conclude that children with hypothalamic 
damage have a significant incidence of obesity. 
Despite raised serum leptin levels, they retain the 
relationship between leptin and BMI SDS. This 
along with low leptin binding activity suggests that 
leptin secretion in those with hypothalamic damage 
increases unchecked by any central negative 
feedback. 
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